Shoora Designs Enterprise Value (EV)

Shoora Designs Ltd Enterprise Value

The Shoora Designs Ltd Enterprise Value is a key financial metric used by investors to evaluate Shoora Designs Ltd's valuation, profitability, and overall financial performance. Tracking the Shoora Designs Ltd Enterprise Value helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.

Shoora Designs Ltd (NSE: , BSE: 543970) is currently trading at ₹52.78, with a market capitalization of ₹244.04M. As a leading company in the Consumer durables sector and Other consumer specialties industry, monitoring the Shoora Designs Ltd Enterprise Value is essential for fundamental analysis.

Shoora Designs Ltd Enterprise Value Current Value

The current Shoora Designs Ltd Enterprise Value stands at 49.87M.

The Shoora Designs Ltd Enterprise Value has declined compared to earlier levels, suggesting improved fundamentals or more attractive valuation.

Shoora Designs Ltd Enterprise Value Historical Trend

The Shoora Designs Ltd Enterprise Value has shown the following historical trend:

• 2024: 49.87M
• 2023: 55.71M
• 2021: 0
• 2020: 0

The decline in Shoora Designs Ltd Enterprise Value indicates improving financial efficiency or better earnings growth.

What Shoora Designs Ltd Enterprise Value Indicates for Investors

The Shoora Designs Ltd Enterprise Value plays a crucial role in understanding the company's financial health and valuation.

This ratio is an important metric used in fundamental analysis of Shoora Designs Ltd.

Shoora Designs Ltd Enterprise Value Analysis Summary

The Shoora Designs Ltd Enterprise Value remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Shoora Designs Ltd Enterprise Value should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.

Regular tracking of Shoora Designs Ltd Enterprise Value helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.